Coadex index

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Index to record the most important, practical criteria regarding the clinical relevance of type IV sensitization.

General informationThis section has been translated automatically.

After reading an epicutaneous test or photopatch test, an evaluation of the clinical relevance of the type IV sensitization present must always be made. All information should then be documented for the patient in an allergy pass. It is useful to indicate the clinical relevance with reference to the allergen in the passport. The so-called COADEX index comprises the most important, practice-relevant criteria regarding clinical relevance:
  • C (current): current clinical relevance. The patient was exposed to the allergen and now presents with clinical symptoms, which will however improve when the patient is not exposed to the allergen.
  • O (old): past clinical relevance. The patient has been exposed to the allergen in the past and developed clinical symptoms, but these are not present.
  • A (actively sensitized): the patient is actively sensitized.
  • D (do not know): relevance remains unclear.
  • EX (exposed): history of allergen exposure without clinical symptoms or no history of allergen exposure in case of positive type IV sensitization in the epicutaneous test.

Note(s)This section has been translated automatically.

The clinical relevance of sensitization to finished products (e.g. cosmetics) can be determined by means of a use-use test.

LiteratureThis section has been translated automatically.

  1. Bourke J et al (2001) Guidelines for care of contact dermatitis. Br J Dermatol 145: 877-885
  2. Bruynzeel DP et al (2004) Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol 18: 679-682
  3. Villarama CD et al (2004) Correlations of patch test reactivity and the repeated open application test(ROAT)/provocative use test (PUT). Food Chem Toxicol 42: 1719-1725

Authors

Last updated on: 29.10.2020